Multilingual abstract
Introduction
Methodology
Results
Public research impact studies
Case of Singapore PRIs
Mean | Standard deviation | |
---|---|---|
Size | ||
Start-ups | 0.12 | 0.32 |
Small and medium enterprises (SME) | 0.52 | 0.50 |
Multi-national corporations (MNC) and large enterprises | 0.40 | 0.49 |
Sector | ||
Biomedical sciences | 0.37 | 0.48 |
Info-comm | 0.30 | 0.46 |
Engineering and manufacturing | 0.21 | 0.41 |
Electronics, materials, chemical and other | 0.12 | 0.33 |
Binary logistic regression (H1, H2) | ||||
---|---|---|---|---|
Variables | DV: firm’s propensity to repeat licensing (N = 835) | |||
Model 1 | Model 2 | Model 3 | Model 4 | |
Constant | −0.44(0.37) | 0.47(0.61) | 0.29(0.22) | 0.49(0.65) |
Start-up | 0.13(0.31) | 0.20(0.32) | −0.66***(0.35) | −0.66***(0.35) |
SME | 1.79**(0.30) | 1.74**(0.30) | 0.72*(0.32) | 0.67*(0.33) |
MNC and large enterprises | 1.85**(0.30) | 1.82**(0.30) | 0.91**(0.32) | 0.88*(0.32) |
Biomedical sciences sector | 0.61***(0.31) | 0.42(0.32) | −0.01(0.35) | 0.01(0.35) |
Info-comm sector | 0.49(0.31) | 0.47(0.31) | 0.24(0.33) | 0.24(0.33) |
Engineering and manufacturing sectors | −0.65*(0.30) | −0.64*(0.3) | −0.79*(0.33) | −0.82*(0.33) |
Log_IP licensing costs | −0.23***(0.12) | −1.79**(0.23) | −1.85**(0.24) | |
Log_RICV | 1.67**(0.21) | 1.70**(0.21) | ||
Log_RICV × Log_IP licensing costs | −0.10(0.11) | |||
Cox and Snell R square | 0.08 | 0.08 | 0.17 | 0.17 |
Nagelkerke R square | 0.13 | 0.13 | 0.27 | 0.27 |
Model chi-square | 69.76 | 73.42 | 157.73 | 158.57 |
Significance | 0 | 0 | 0 | 0 |
Classification correct | 78 % | 78 % | 82 % | 83 % |
Discussion
Inventive output of universities/PRI
Inventive output indicators | Authors |
---|---|
Disclosures | Chapple et al. 2005
|
Disclosures, patents | Carlsson and Fridh 2002
|
Gulbrandsen and Rasmussen 2012
| |
Park et al. 2010
| |
Knowledge infrastructure | Keane and Allison 1999
|
Non-resident tuition rate | Baryla and Dotterweich 2001
|
Patent citations | Beaudry and Kananian. 2013
|
Jaffe et al. 1993
| |
Meyer 2006
| |
Owen-Smith and Powell 2003
| |
Spencer 2001
| |
Wang et al. 2011
| |
Patents | Agrawal and Henderson 2002
|
Bach and Llerena 2007
| |
Baldini 2010
| |
Bekkers and Freitas 2008
| |
Bozeman and Kingsley 1997
| |
Bozeman and Klein 1999
| |
Fischer and Varga 2003
| |
Georghiou and Roessner 2000
| |
Huggins and Johnston 2009
| |
Lissoni et al. 2013. | |
PRI-firm collaboration | Sáez et al. 2002
|
Publication citations | Abramo et al. 2009b
|
Tornquist and Hoenack 1996
| |
Publication co-authorship | Abramo et al. 2011
|
Abramo et al. 2009a
| |
Publications | Arundel and Geuna 2004
|
Cohen et al. 2002
| |
Publications, budget | Rogers et al. 1999
|
Publications, patents | Dietz and Bozeman 2005
|
Nelson 2009
| |
Publications, patents and citations | McMillan et al. 2000
|
Narin, Hamilton and Olivastro 1995 | |
Narin et al. 1997
| |
R&D intensity | Nelson 1986
|
R&D stocks, patents, citations | Hall et al. 2005
|
University-industry research collaboration | Villasana 2011
|
Commercialisation output of universities/PRIs by TTOs
Commercialisation output indicators | Authors |
---|---|
Licensees that go IPO, royalties | Powers and McDougall 2005a
|
Licenses | Bach and Llerena 2007
|
Bekkers and Freitas 2008
| |
Carlsson and Fridh 2002
| |
Heisey and Adelman 2011
| |
Hewitt-Dundas 2012
| |
Huggins and Johnston 2009
| |
Lach and Schankerman 2008
| |
Nelson 2009
| |
Sine et al. 2003
| |
Licenses, spin-offs | Bozeman and Kingsley 1997
|
Bozeman and Klein 1999
| |
Georghiou, and Roessner 2000
| |
Gulbrandsen and Rasmussen 2012
| |
Maia and Claro 2013
| |
McAdam et al. 2009
| |
Pries and Guild 2011
| |
Rogers et al. 1999
| |
Rogers et al. 2000
| |
New biotech enterprises | Zucker et al. 1998
|
No of spin-offs that go IPO | Powers and McDougall 2005b
|
Spin-off rate | Bania et al. 1993
|
Colombo et al. 2010
| |
Di Gregorio and Shane 2003
| |
Spin-offs | Bach and Lambert 1992
|
Harhoff 1999
| |
Jacobsson and Vico 2010
| |
Lehrer et al. 2009
| |
Lockett and Wright 2005
| |
Marion et al. 2012
| |
Miner et al. 2012
| |
O’Shea et al. 2005
| |
O'Shea et al. 2007
| |
Probert et al. 2013
| |
Rasmussen and Borch 2010
| |
Tassey 1999
| |
Technology transfer | Coccia 2008. |
Innovation of industry or firms
Innovation indicators | Authors |
---|---|
Innovation input | |
Corporate patent linked to university papers | Agrawal and Cockburn 2003
|
Corporate patents | Jaffe 1989
|
Corporate patents, R&D expenditure | Autant-Bernard 2001
|
Corporate R&D | Boardman and Gray 2010
|
Corporate R&D and innovation | De Fuentes and Dutrenit 2012
|
Corporate R&D stocks linked to universities | Adams 2002
|
Corporate patenting rate | Hu 2008
|
Induced investment | Giesecke 2000
|
Kramer et al. 1997
| |
Pressman et al. 1995
| |
Industry-owned patents | Lawson 2013a
|
Lawson 2013b
| |
Innovative expenditure | Beugelsdijk and Cornet 2002
|
Investment in building and equipment | Florax and Folmer 1992
|
R&D intensity | Hauknes and Knell 2009
|
Research collaboration | Martin 1998
|
Innovation outcome indicators | |
Innovation sales | Beugelsdijk and Cornet 2002
|
Lööf and Broström 2008
| |
Innovative count | Anselin et al. 1997
|
Innovative output of firms | Acs et al. 1994
|
Innovative products | Beise and Stahl 1999
|
Varga 2000
| |
New product innovation sales | Eom and Lee 2010
|
New products | |
New products and processes | Rosenberg and Nelson 1994
|
No. of drugs entering each clinical R&D stage (from NIH grant expenditure) | Blume-Kohout 2012
|
Product and process innovation | Bozeman and Kingsley 1997
|
Bozeman and Klein 1999
| |
Coccia 2008
| |
Conceição et al. 1998
| |
Georghiou, and Roessner 2000
| |
Kingsley et al. 1996
| |
Klevorick et al. 1995
| |
Sales and profitability | Bozeman 2000
|
Sales growth rate | Evangelista and Vezzani 2010
|
Sales of new products, improved products and products with no or incremental changes | Faems et al. 2005
|
Sales of products and services of spin-offs | Vincett 2010
|
Sales per employee | Barajas et al. 2012
|
Lööf and Heshmati 2002
|
Community/economy
Economic impact indicators | Authors |
---|---|
Country competitiveness | van Hemert and Nijkamp 2010
|
Earnings of non-farm worker | Goldstein and Drucker 2006
|
Goldstein and Renault 2004
| |
Economic growth | Bozeman 2000
|
Employment | Conceição et al. 1998
|
Kramer et al. 1997
| |
Pressman et al. 1995
| |
Riddel and Schwer. 2003
| |
Swann and Prevezer 1996
| |
Employment and income | Armstrong 1993
|
Brownrigg 1973
| |
Lewis 1988
| |
Employment and output | Glasson 2003
|
Employment growth | Henderson and Weiler 2010
|
Lendel 2010
| |
Employment, income and output | Felsenstein 1996
|
Harris 1997
| |
Pastor et al. 2013, | |
Roessner et al. 2013
| |
Employment, output and income | Roessner et al. 2010
|
Expenditures from staff and students | Steinacker 2005
|
GDP contributed by university R&D | Martin 1998
|
GDP growth and income growth | Baldwin and McCracken 2013
|
Human capital | Huffman and Quigley 2002
|
Nagle 2007
| |
Perkmann et al. 2011
| |
Income and output | Bleaney et al. 1992
|
Jobs created | Gulbrandsen and Rasmussen 2012
|
Miner et al. 2012
| |
Wallmark 1997
| |
Physical capital or labour | Tassey 2005
|
Private and social rates of return on projects | Weiler 2000
|
Private and social rates of return to public R&D | Jamison and Jansen 2000
|
Salter and Martin 2001
| |
Property rent | Sivitanidou and Sivitanides 1995
|
Social rate of return on academic research | |
Value-add | Huggins and Johnston 2009
|